|
CN112010864A
|
|
Vascular endothelial growth factor receptor inhibitor and preparation method and application thereof
|
|
WO2020156271A1
|
|
Janus kinase (jak) family inhibitor, preparation of same, and applications thereof
|
|
CN111518096A
|
|
Janus kinase JAK family inhibitor and preparation and application thereof
|
|
CN111073914A
|
|
Process for preparing trans-1, 2-cyclohexanedimethanol
|
|
WO2020001350A1
|
|
Egfr inhibitor, method for preparing the same, and uses thereof
|
|
WO2020001351A1
|
|
Egfr inhibitor, method for preparing the same, and uses thereof
|
|
CN110642836A
|
|
EGFR inhibitor and preparation and application thereof
|
|
CN110642838A
|
|
EGFR inhibitor and preparation and application thereof
|
|
WO2019233458A1
|
|
Vegfr inhibitor, preparation method therefor and use thereof
|
|
WO2019233459A1
|
|
Human epidermal growth factor receptor inhibitor, preparation method therefor and use thereof
|
|
WO2019233461A1
|
|
Tropomyosin receptor kinase inhibitor, preparation method therefor and use thereof
|
|
CN110577546A
|
|
VEGFR inhibitor and preparation method and application thereof
|
|
CN110577514A
|
|
human epidermal growth factor receptor inhibitor and preparation method and application thereof
|
|
CN110577532A
|
|
Tropomyosin receptor kinase inhibitor and preparation method and application thereof
|
|
CN111285867A
|
|
Preparation method of benzoquinolizine derivative
|
|
AU2018419112A1
|
|
Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
|
|
CN109970620A
|
|
A method of preparing onglyza intermediate
|
|
CN108420798A
|
|
A kind of immediate release drug formulations of anti-coagulants and preparation method thereof
|
|
CN107641081A
|
|
A kind of preparation method of pharmaceutical intermediate
|
|
CN107638403A
|
|
A kind of hard capsule preparation
|
